Neural and immune mechanisms in the pathogenesis of Parkinson's disease

Research output: Contribution to journalArticlepeer-review


Although almost 50 years have passed since impaired dopaminergic transmission was identified as the main neurochemical defect in Parkinson's disease (PD), the cause of the disease remains unknown. A restricted number of biological mechanisms are likely to contribute to the process of cell death in the nigrostriatal pathway. These mechanisms include mitochondrial defects and enhanced formation of reactive oxygen species - leading to oxidative damage - and abnormal protein aggregation. In addition to or, possibly, intermingled with these mechanisms of neuronal damage there is another crucial factor: neuroinflammation. The inflammatory response associated with cell loss in the dopaminergic nigrostriatal tract and, more in general, the role of immune mechanisms are increasingly recognized in PD pathogenesis. Neuroinflammatory changes have been repeatedly demonstrated, in both neurotoxic and transgenic animal models of PD, as well as in PD patients. Transgenic models based on α-synuclein overexpression, in particular, have provided crucial insights into the correlation between this protein and the dichotomous response that microglia can activate, with the polarization toward a cytotoxic (M1) or cytoprotective (M2) phenotype. Full understanding of such mechanisms may set the ground for a fine tuning of the neuroinflammatory process that accompanies and sustains neurodegeneration, thereby opening new therapeutic perspectives for PD.

Original languageEnglish
Pages (from-to)189-201
Number of pages13
JournalJournal of NeuroImmune Pharmacology
Issue number1
Publication statusPublished - Mar 2013


  • Microglia
  • Neuroinflammation
  • Striatum
  • Substantia nigra pars compacta
  • Synuclein

ASJC Scopus subject areas

  • Pharmacology
  • Immunology and Allergy
  • Immunology
  • Neuroscience (miscellaneous)


Dive into the research topics of 'Neural and immune mechanisms in the pathogenesis of Parkinson's disease'. Together they form a unique fingerprint.

Cite this